Key result
The Thrombovette blood sampling tube improved the positive predictive value for detecting clopidogrel resistance and ASA resistance compared to citrate tubes.
Why the study?
Does the Thrombovette blood sampling tube improve the validity of platelet function diagnostics for detecting ASA and clopidogrel resistance compared to citrate tubes?
Cross-Sectional (n=66)
Does the Thrombovette blood sampling tube improve the validity of platelet function diagnostics for detecting ASA and clopidogrel resistance compared to citrate tubes?
The Thrombovette blood sampling tube demonstrates improved predictive values for detecting clopidogrel resistance compared to standard citrate tubes.
Answers are grounded in this paper and cite their sources.
Thrombovette tubes may improve PPV for resistance detection in diagnostics; hypothesis-generating and requires prospective validation before practice change.
Background: The difficult pre-analytical conditions of platelet function diagnostics discourage its widespread use, e.g., to detect resistance to acetylsalicylic acid (ASA) and/or clopidogrel. Platelet activation during blood drawing and sample preparation cannot be prevented by citrate anticoagulation. Here, we tested a new blood sampling tube containing the anticoagulant benzylsulfonyl-D-Argininyl-Prolyl-4-amidinobenzylamide (Thrombovette®, Probe&go, Germany). Methods: A total of 46 emergency patients taking ASA and clopidogrel as well as 20 healthy volunteers were included in the study. Blood was drawn into Thrombovette® and citrate S-Monovette® tubes (Sarstedt AG&Co, Germany) and transported to the laboratory via the pneumatic tube system. Whole blood impedance aggregometry (model 560Ca, Chrono-Log, Havertown, PA, USA) was performed using collagen and ADP as platelet agonist (final concentrations 1 mg/L and 5 μM, respectively). Results: Reference ranges and cut-off values for the determination of drug resistance were obtained from the healthy cohort. Positive predictive values were 94.6% and 94.1% for inhibition of aggregation by ASA, and 68.0% and 53.3% for inhibition by clopidogrel using Thrombovette® and citrate S-Monovette®, respectively. Negative predictive values were 82.8% and 75.0% for ASA resistance and 87.8% and 83.3% for clopidogrel resistance using Thrombovette® and citrate S-Monovette®, respectively. Conclusions: Thrombovette® is a promising new system for blood sampling and could improve the validity of platelet function diagnostics.
No takes yet. Share an insight, caveat, or question.
Wolf et al. (2010) conducted a cross-sectional in Patients taking ASA and clopidogrel (n=66). Thrombovette blood sampling tube vs. Citrate S-Monovette tubes was evaluated on Positive predictive value for inhibition of aggregation by ASA. The Thrombovette blood sampling tube improved the positive predictive value for detecting clopidogrel resistance and ASA resistance compared to citrate tubes.
Synapse has enriched 10 related papers. Consider them for comparative context: